arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Philip Morris International Inc

PM Health Care Medicinal Chemicals and Botanical Products
$201.74
▲ +0.9% Today
as of Oct 22, 16:51 ET
Last 30 days +3.53% Sep 14 → Oct 22
$186.01 $191.27 $196.52 $201.77 $207.03 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$197.04
High
$201.88
Low
$197.00
Volume
$5M
Avg Vol
$5M
Mkt Cap
$300.3B
P/E (TTM)
36.71
Beta
—
52w High
$210.45
52w Low
$142.11
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

lean bull ▲ 4 ● 21 ▼ 0
Oct 22 · 09:50 StockStory neutral
PM Q3 deep dive: smoke-free growth and U.S. investment shape outlook
Oct 22 · 05:12 TIKR neutral
Philip Morris Beat Q3, Then Handed It Back: ZYN’s 25% Price Cut Explained
Oct 22 · 01:23 Motley Fool neutral
Philip Morris: 3 Key Takeaways for Long-Term Investors
▸ Show all 25 press releases & news Free account →

PM earnings at a glance

The options market is pricing a move of about ±6.1% after the report, a range of roughly $189.38 to $214.10 from today's $201.74. Over its last 6 reports the stock rose the next day 4 times and fell 2, moving ±4.2% on average; after the most recent report on Jul 22, 2026 it moved +3.3%. That means options currently expect more movement than PM has typically delivered. PM beat the consensus EPS estimate in 6 of its last 6 reported quarters. Implied volatility is currently 38%. The share price of $201.74 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$142
$210
87% of range
Avg surprise (last 6)
+5.4%
Avg reaction (last 6)
+0.2%
67% positive
Latest IV / EM
38%
EM ±6.1% · $200 · Oct 23

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.01$1.32$1.62$1.93$2.24 Actual $1.28Actual $1.01Actual $1.32Actual $1.38Actual $1.54Actual $1.97Actual $1.69Est $1.61Actual $1.91Est $1.85Actual $2.24Est $2.10Actual $1.70Est $1.67Actual $1.96Est $1.82Actual $2.20Est $2.04 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258K8KJun/2026
Revenue vs Net Income Revenue Net income
$0$2.9B$5.9B$8.8B$11.8B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Jul 22, 2026Jun/2026 $2.20 $2.04 +7.8% +6.8% +3.3% earnings
Wed Apr 22, 20268K 2026-04-22 $1.96 $1.82 +7.7% — +7.0% earnings
Fri Feb 6, 20268K 2026-02-06 $1.70 $1.67 +1.8% — +0.4% earnings
Tue Oct 21, 2025Sep/2025 $2.24 $2.10 +6.7% — -3.8% earnings
Tue Jul 22, 2025Jun/2025 $1.91 $1.85 +3.2% — -8.4% earnings
Wed Apr 23, 2025Mar/2025 $1.69 $1.61 +5.0% — +2.4% earnings
Mon Sep 30, 2024Sep 2024 $1.97 — — — — financials
Sun Jun 30, 2024Jun 2024 $1.54 — — — — financials
Sun Mar 31, 2024Mar 2024 $1.38 — — — — financials
Sat Sep 30, 2023Sep 2023 $1.32 — — — — financials
Fri Jun 30, 2023Jun 2023 $1.01 — — — — financials
Fri Mar 31, 2023Mar 2023 $1.28 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$11.19B$10.15B—$10.85B$10.14B$9.30B—$9.91B
Cost of revenue$3.53B$3.24B—$3.49B$3.27B$3.03B—$3.37B
Gross profit$7.66B$6.91B—$7.36B$6.87B$6.27B—$6.54B
Operating income$4.53B$3.89B—$4.26B$3.71B$3.54B—$3.65B
Net income$2.82B$2.44B—$3.48B$3.04B$2.69B—$3.08B
EPS (diluted)$1.80$1.56—$2.23$1.95$1.72—$1.97

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$6.00B$5.45B$4.87B$4.04B$4.14B$4.44B$4.22B$4.26B
Inventory$11.44B$11.39B$11.48B$10.27B$10.73B$10.13B$9.45B$9.36B
Total current assets$26.01B$25.60B$24.36B$22.66B$23.36B$22.20B$20.17B$20.80B
Total assets$68.27B$68.91B$69.19B$67.06B$68.51B$65.08B$61.78B$66.89B
Long-term debt————————
Total liabilities$74.93B$76.21B$77.21B$76.05B$78.52B$74.00B$71.65B$74.61B
Total equity$-8.58B$-7.30B$-9.99B$-10.91B$-10.01B$-8.93B$-11.75B$-7.71B

Implied volatility — last 90 days

26%38%51%63%76% Jun 07 — IV 34% · EM ±3.2%Jun 08 — IV 35% · EM ±2.9%Jun 09 — IV 33% · EM ±2.4%Jun 10 — IV 40% · EM ±2.3%Jun 11 — IV 44% · EM ±1.8%Jun 15 — IV 35% · EM ±2.5%Jun 16 — IV 37% · EM ±2.2%Jun 17 — IV 45% · EM ±1.9%Jun 19 — IV 34% · EM ±3.8%Jun 22 — IV 41% · EM ±3.4%Jun 23 — IV 34% · EM ±2.5%Jun 24 — IV 35% · EM ±2.1%Jun 25 — IV 43% · EM ±1.8%Jun 29 — IV 36% · EM ±7.5%Jun 30 — IV 37% · EM ±7.6%Jul 01 — IV 36% · EM ±7.3%Jul 02 — IV 37% · EM ±7.3%Jul 03 — IV 39% · EM ±7.5%Jul 06 — IV 39% · EM ±7.0%Jul 07 — IV 43% · EM ±7.4%Jul 08 — IV 41% · EM ±6.8%Jul 09 — IV 41% · EM ±6.6%Jul 10 — IV 41% · EM ±6.5%Jul 13 — IV 46% · EM ±6.3%Jul 14 — IV 49% · EM ±6.4%Jul 15 — IV 48% · EM ±6.0%Jul 16 — IV 50% · EM ±6.0%Jul 17 — IV 52% · EM ±5.7%Jul 20 — IV 65% · EM ±5.4%Jul 21 — IV 76% · EM ±5.5%Jul 22 — IV 43% · EM ±2.6%Jul 23 — IV 50% · EM ±2.1%Jul 27 — IV 34% · EM ±2.8%Jul 28 — IV 34% · EM ±2.5%Jul 29 — IV 42% · EM ±2.5%Jul 30 — IV 38% · EM ±1.6%Aug 03 — IV 35% · EM ±2.9%Aug 04 — IV 40% · EM ±2.9%Aug 05 — IV 40% · EM ±2.4%Aug 06 — IV 38% · EM ±1.6%Aug 10 — IV 29% · EM ±2.5%Aug 11 — IV 28% · EM ±2.1%Aug 12 — IV 29% · EM ±1.7%Aug 13 — IV 35% · EM ±1.4%Aug 17 — IV 29% · EM ±2.4%Aug 18 — IV 34% · EM ±2.5%Aug 19 — IV 33% · EM ±1.9%Aug 20 — IV 49% · EM ±2.0%Aug 24 — IV 31% · EM ±2.5%Aug 25 — IV 27% · EM ±2.0%Aug 26 — IV 28% · EM ±1.7%Aug 27 — IV 35% · EM ±1.4%Aug 31 — IV 27% · EM ±2.3%Sep 01 — IV 28% · EM ±2.1%Sep 02 — IV 34% · EM ±2.0%Sep 03 — IV 46% · EM ±1.9%Sep 07 — IV 34% · EM ±2.8%Sep 08 — IV 34% · EM ±2.4%Sep 09 — IV 37% · EM ±2.2%Sep 10 — IV 31% · EM ±1.3%Sep 14 — IV 29% · EM ±2.4%Sep 15 — IV 29% · EM ±2.1%Sep 16 — IV 38% · EM ±2.2%Sep 17 — IV 32% · EM ±1.3%Sep 21 — IV 26% · EM ±2.2%Sep 22 — IV 34% · EM ±2.5%Sep 23 — IV 33% · EM ±1.9%Sep 24 — IV 42% · EM ±1.7%Sep 28 — IV 32% · EM ±6.6%Sep 29 — IV 33% · EM ±6.7%Sep 30 — IV 33% · EM ±6.6%Oct 01 — IV 34% · EM ±6.6%Oct 02 — IV 34% · EM ±6.5%Oct 06 — IV 35% · EM ±6.1%Oct 07 — IV 37% · EM ±6.2%Oct 08 — IV 38% · EM ±6.1%

Sector peers

MO
Altria Group
$115.8B $76.07+1.9%
RLX
RLX Technology Inc.
$2.1B $1.64-2.4%
OBIO
Orchestra BioMed Holdings, Inc.
$382M $5.47-6.0%
SNDL
SNDL Inc.
$308M $1.29+0.8%
USNA
USANA Health Sciences, Inc.
$271M $14.52-1.4%
NAGE
Niagen Bioscience, Inc.
$215M $2.52+0.4%

PM earnings FAQ

What is PM's expected move for earnings?

Options currently price a move of about ±6.1%, or $12.36 per share either way from $201.74.

How does PM stock usually react to earnings?

Across the last 6 reports the average next-day move was ±4.2%, up 4 times and down 2 times.

What is PM's implied volatility?

PM's at-the-money implied volatility is about 38% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in